This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

NHSC. Lapatinib in combination with capecitabine and oxaliplatin for advanced gastric, oesophageal or gastro-oesophageal cancer – first line. Birmingham: National Horizon Scanning Centre (NHSC). Horizon Scanning Review. 2012

Subject indexing assigned by CRD

Antineoplastic Combined Chemotherapy Protocolss; Esophageal Neoplasms; Quinazolines; Receptor, ErbB-2; Stomach Neoplasms

English

England

An English language summary is available.

The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269 Email: c.packer@bham.ac.uk

32012000076

13/07/2012